SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Capital Work in Progress History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹17 Cr | ₹15 Cr | ₹3.09 Cr | ₹2.05 Cr | - |
What is the latest Capital Work in Progress ratio of SHREE GANESH REMEDIES ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹17 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹3.09 Cr |
Mar2021 | ₹2.05 Cr |
Mar2020 | - |
How is Capital Work in Progress of SHREE GANESH REMEDIES Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹17 Cr | 9.67 | |
Mar2023 | ₹15 Cr | 390.17 | |
Mar2022 | ₹3.09 Cr | 51.03 | |
Mar2021 | ₹2.05 Cr | 0 | |
Mar2020 | - | - |
Compare Capital Work in Progress of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹1,081.2 Cr | 27.6% | 24.6% | 6.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 27.6% |
24.6% |
6.7% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses